EGFR and cancer: Human epidermal growth factor receptor 3 (HER3), also a member of the EGFR/ERBB family of receptor tyrosine kinases, plays a crucial role in cancer progression by activating the PI3K-AKT-mTOR pathway upon heterodimerization with other receptors [153].